Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • agroster
    Member
    • Jan 2010
    • 13

    Illumina assemblies (w/ Edena) into Celera assembler

    Hi,
    I am doing de novo assembly with a lot of 454 and Illumina data that i have for my 7.3 Mb bacterial genome.

    Data i have:
    1.5 million 454 FLX and Titanium reads (average length ~320 bp)
    160 000 mate-pair mates from a 10 kb 454 Tit library

    33 million Illumina reads (36 bp)

    Given a lack of computing power, i've been using the Celera Assembler to assemble, de novo, the 454 data, and it has been giving nice results, with scaffolds up to 3.3 Mb and contigs up to 480 kb.

    Independently, I've used EDENA to assemble the Illumina data (i can't use velvet - not enough RAM), getting contigs up to 17 Kb.

    Ideally, I'd use MIRA to do a combined 454/Illumina assembly, but i can't given my lack of RAM.

    What I'd like to do is take the EDENA/Illumina contigs and incorporate them into the Celera Assembly. This was done similarly with vcake/Illumina contigs into Newbler/454 in this paper:

    De novo assembly using low-coverage short read sequence data from the rice pathogen Pseudomonas syringae pv. oryzae


    However, I don't know how to incorporate the EDENA/Illumina contigs so that they can be used by Celera assembler. Has anyone done this?

    Any guidance would be appreciated!

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
19 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
26 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
38 views
0 reactions
Last Post SEQadmin2  
Working...